Researchers at University of Miami Miller School of Medicine, collaborating with a team of doctors and surgeons, have uncovered how the drug Rituximab, normally used to treat non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia, also works to prevent FSGS from recurring in children and young adults with kidney transplants. The drug appears to bind … Continue reading Cancer Drug May Help Stop Recurring FSGS in Kidney Transplant Patients
Skip to content
UKRO – University Kidney Research Organization
Together We Build a Kidney